Search | OpenScholar

Search results

1498 results found

Members of the IPMDS Rating Scales Review Committee. Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations. 2023 Jun;38(6):1008-1026. doi: 10.1002/mds.29392. Epub 2023 Apr 20. PMID: 37081740

Publication: Journal Article

Martino, D, V Karnik, R Bhidayasiri, DA Hall, RA Hauser, A Macerollo, TM Pringheim, et al. 2023. “Members of the IPMDS Rating Scales Review Committee. Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations. 2023 Jun;38(6):1008-1026. Doi: 10.1002/Mds.29392. Epub 2023 Apr 20. PMID: 37081740”. Mov Disord.

Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment. Neurol Ther. 2022 Mar;11(1):459-469. doi: 10.1007/s40120-021-00317-5. Epub 2022 Feb 2. PMID: 35107750.

Publication: Journal Article

Hauser, RA, A Favit, LA Hewitt, A Lindsten, S Gomy, S Kymes, and SH Isaacson. 2022. “Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment. Neurol Ther. 2022 Mar;11(1):459-469. Doi: 10.1007/S40120-021-00317-5. Epub 2022 Feb 2. PMID: 35107750.”. Neurol Ther.

P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson's Disease. Adv Ther. 2022 May;39(5):1881-1894. doi: 10.1007/s12325-022-02097-2. Epub 2022 Mar 10. PMID: 35267155.

Publication: Journal Article

Hauser, RA, N Giladi, W Poewe, J Brotchie, H Friedman, S Oren, and P Litman. 2022. “P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease. Adv Ther. 2022 May;39(5):1881-1894. Doi: 10.1007/S12325-022-02097-2. Epub 2022 Mar 10. PMID: 35267155.”. Adv. Ther.

Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study. 2022 Feb 23;13:773999. doi: 10.3389/fneur.2022.773999. eCollection 2022. PMID: 35280262.

Publication: Journal Article

Hauser, RA, H Barkway, HH Fernandez, SA Factor, J Jimenez-Shahed, N Gross, L Marinelli, et al. 2022. “Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study. 2022 Feb 23;13:773999. Doi: 10.3389/Fneur.2022.773999. ECollection 2022. PMID: 35280262.”. Front Neurol.

Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine. 2022 Mar 2;97:47-51. doi: 10.1016. Epub 2022 Mar 2.PMID: 35299070.

Publication: Journal Article

Hauser, RA, H Barkay, A Wilhelm, M Wieman, JM Savola, and MF Gordon. 2022. “Minimal Clinically Important Change in Abnormal Involuntary Movement Scale Score in Tardive Dyskinesia As Assessed in Pivotal Trials of Deutetrabenazine. 2022 Mar 2;97:47-51. Doi: 10.1016. Epub 2022 Mar 2.PMID: 35299070.”. Parkinsonism Relat Disord.

Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson's disease. 2022 Mar 18;8(1):29. doi: 10.1038/s41531-022-00291-1. PMID: 35304480.

Publication: Journal Article

Hauser, RA, J Lytle, AE Formella, and CM Tanner. 2022. “Amantadine Delayed Release/Extended Release Capsules Significantly Reduce OFF Time in Parkinson’s Disease. 2022 Mar 18;8(1):29. Doi: 10.1038/S41531-022-00291-1. PMID: 35304480.”. NP J Parkinsons Dis.

Reprogramming of human fibroblasts toward a cardiac fate.

Publication: Journal Article

Nam, Young-Jae, Kunhua Song, Xiang Luo, Edward Daniel, Kaleb Lambeth, Katherine West, Joseph A Hill, et al. 2013. “Reprogramming of Human Fibroblasts Toward a Cardiac Fate.”. Proceedings of the National Academy of Sciences of the United States of America 110 (14): 5588-93.

Infectious Bursal Disease Virus Structural Protein VP2 Expressed by a Baculovirus Recombinant in Bombyx mori.

Publication: Journal Article

Song, Kun-Hua, Yong-Feng Jin, Yao-Wei Huang, Yao-Zhou Zhang, and Lian Yu. 2000. “Infectious Bursal Disease Virus Structural Protein VP2 Expressed by a Baculovirus Recombinant in Bombyx Mori.”. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochimica et Biophysica Sinica 32 (3): 281-84.

Our Team

Page

Kunhua Song

Person: Principal Investigator

Dr. Kunhua Song is an Associate Professor of Internal Medicine at the USF Health Heart Institute. He earned a B.S. in Biology from Fudan University, an M.A. from Zhejiang University, China, an M.S. from the University of Arkansas, and a Ph.D. in Genetics and Development from the University of Texas...